JP2021530470A5 - - Google Patents
Info
- Publication number
- JP2021530470A5 JP2021530470A5 JP2021500105A JP2021500105A JP2021530470A5 JP 2021530470 A5 JP2021530470 A5 JP 2021530470A5 JP 2021500105 A JP2021500105 A JP 2021500105A JP 2021500105 A JP2021500105 A JP 2021500105A JP 2021530470 A5 JP2021530470 A5 JP 2021530470A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- compound
- cathepsin
- unsubstituted
- alkyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018093886 | 2018-06-30 | ||
| CNPCT/CN2018/093886 | 2018-06-30 | ||
| PCT/CN2019/092488 WO2020001392A1 (en) | 2018-06-30 | 2019-06-24 | Cathepsin c inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530470A JP2021530470A (ja) | 2021-11-11 |
| JPWO2020001392A5 JPWO2020001392A5 (https=) | 2022-07-01 |
| JP2021530470A5 true JP2021530470A5 (https=) | 2022-07-01 |
Family
ID=68986057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021500105A Pending JP2021530470A (ja) | 2018-06-30 | 2019-06-24 | カテプシンｃ阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210114983A1 (https=) |
| EP (1) | EP3814324A4 (https=) |
| JP (1) | JP2021530470A (https=) |
| CN (1) | CN112601742A (https=) |
| WO (1) | WO2020001392A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12030875B2 (en) | 2018-09-07 | 2024-07-09 | PIC Therapeutics, Inc. | EIF4E inhibitors and uses thereof |
| AU2021230289A1 (en) | 2020-03-03 | 2022-09-29 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| CN112920124B (zh) * | 2021-01-29 | 2024-03-01 | 安徽医科大学 | 一种嘧啶-2,4-二胺类化合物及其制备方法与应用 |
| US12157732B2 (en) | 2021-08-25 | 2024-12-03 | PIC Therapeutics, Inc. | eIF4E inhibitors and uses thereof |
| JP2024534127A (ja) | 2021-08-25 | 2024-09-18 | ピク セラピューティクス， インコーポレイテッド | ｅＩＦ４Ｅ阻害剤及びその使用 |
| TW202413352A (zh) * | 2022-06-13 | 2024-04-01 | 日商模數探索股份有限公司 | 氮雜環烷基羰基環狀胺化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101705158B1 (ko) * | 2009-05-05 | 2017-02-09 | 다나-파버 캔서 인스티튜트 인크. | Ｅｇｆｒ 억제제 및 질환 치료방법 |
| WO2012112733A1 (en) * | 2011-02-16 | 2012-08-23 | Glaxosmithkline Llc | Cathepsin c inhibitors |
| CN103664878A (zh) * | 2012-09-12 | 2014-03-26 | 山东亨利医药科技有限责任公司 | 杂芳环及其衍生物类酪氨酸激酶抑制剂 |
| EP3019491A4 (en) * | 2013-07-09 | 2016-12-21 | Dana Farber Cancer Inst Inc | KINASEHEMMER FOR THE TREATMENT OF DISEASES |
| BR112016008632A8 (pt) * | 2013-10-21 | 2020-03-17 | Merck Patent Gmbh | compostos de heteroarila como inibidores de btk, seus usos, e composição farmacêutica |
| US10300058B2 (en) * | 2014-04-18 | 2019-05-28 | Xuanzhu Pharma Co., Ltd. | Tyrosine kinase inhibitor and uses thereof |
| AU2016245434B2 (en) * | 2015-04-07 | 2020-10-29 | Ela Pharma Ltd | Compositions for treating and/or preventing cell or tissue necrosis specifically targeting Cathepsin C and/or CELA1 and/or CELA3A and/or structurally related enzymes thereto |
| CN108137544B (zh) * | 2015-12-10 | 2022-01-04 | 深圳市塔吉瑞生物医药有限公司 | 用于抑制蛋白酪氨酸激酶活性的氨基嘧啶类化合物 |
-
2019
- 2019-06-24 JP JP2021500105A patent/JP2021530470A/ja active Pending
- 2019-06-24 EP EP19826742.9A patent/EP3814324A4/en not_active Withdrawn
- 2019-06-24 WO PCT/CN2019/092488 patent/WO2020001392A1/en not_active Ceased
- 2019-06-24 CN CN201980055883.7A patent/CN112601742A/zh active Pending
-
2020
- 2020-12-30 US US17/137,458 patent/US20210114983A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530470A5 (https=) | ||
| JPWO2023099612A5 (https=) | ||
| JP2016518437A5 (https=) | ||
| HUP0303637A2 (hu) | Nitrogéntartalmú spirotriciklusos-származékok, eljárás előállításukra, valamint ezeket tartalmazó foszfodiészteráz-7-inhibitorként alkalmazható gyógyszerkészítmények | |
| CN114555588A (zh) | 作为axl抑制剂的喹唑啉类化合物 | |
| MX2011009822A (es) | Derivados de tienopirimidinadiona como moduladores del trpa1. | |
| JP2021514400A5 (https=) | ||
| RU2016125306A (ru) | Новые пестицидные соединения и применения | |
| EA035500B1 (ru) | Производные сульфамоилтиофенамида и их применение в качестве медикаментов для лечения гепатита b | |
| JP2013516393A5 (https=) | ||
| MX2011009821A (es) | Derivados de isotiazolo pirimidinadiona como moduladores del trpa1. | |
| JP2017524668A5 (https=) | ||
| EA022420B1 (ru) | Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5) | |
| JP2010504346A5 (https=) | ||
| JP2014526500A5 (https=) | ||
| ME01294B (me) | Nova jedinjenja i kompozicije i metode upotrebe | |
| JP2008516986A5 (https=) | ||
| JPWO2023099624A5 (https=) | ||
| JP2018536678A5 (https=) | ||
| JP2018511647A5 (https=) | ||
| EP2483242A1 (en) | New histone deacetylase inhibitors based simultaneously on trisubstituted 1h-pyrroles and aromatic and heteroaromatic spacers | |
| JP2014532626A5 (https=) | ||
| MX2013008718A (es) | Inhibicion de il17 e ifn-gamma para tratamiento de inflamacion autoinmune. | |
| JP2013517279A5 (https=) | ||
| JP2021535213A5 (https=) |